Trial Profile
An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra(TM) Conventional Oral Tablet With Water.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Diastolic heart failure; Erectile dysfunction; Heart failure; Pulmonary arterial hypertension; Pulmonary hypertension
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 Oct 2009 Actual initiation date (Aug 2009) added as reported by ClinicalTrials.gov.
- 07 Oct 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Sep 2009 Planned initiation date changed from 1 Aug 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov